Newsroom

Newsroom

Welcome to the Apos® Newsroom – where science meets story. Here you’ll find the latest updates, press releases, and real-world moments that move us—one step, one person, one breakthrough at a time. If it’s reshaping the future of movement, it starts here.

Latest updates

September 11, 2025

Latest updates

New Article Points to Breakthrough Nonsurgical Approaches for Knee Osteoarthritis

Addressing Joint Pain With a Medical Device

New Study: Innovative Intervention for Chronic Knee and Back Pain Helps Major Health Provider Reduce Musculoskeletal Spend by 81%

Apos® and ‘Game Recognizes Game’ Podcast Kick Off Bold Campaign to Transform Musculoskeletal Care

Dr. Marty Jaramillo Talks MSK Pain and Reclaiming Movement in New Millennium Magazine Article

The Medical Device that Looks Like a Normal Shoe

LEG UP The 5 things you can do to loosen up ‘creaky knees’ – and when it’s a sign of something more serious

5 proven ways to relieve the pain of creaky knees

New Study Highlights Effectiveness of Apos in Treating Chronic Low Back Pain

Precision Medicine: The Game-Changer For Musculoskeletal Benefits

Novel Shoe Intervention May Cut Low Back Pain, Delay Knee Arthroplasty in Osteoarthritis

How AposHealth Is Revolutionizing Chronic Pain Relief with AI and Wearable Tech

AposHealth® Teams Up with Manifest Media’s Podcast ‘Game Recognizes Game’ to Drive the Next Phase of Growth

World Future Awards 2025

Supporting the management of patients with knee pain to alleviate symptoms

Why Sitting Too Much is Bad for Your Joints

Apos has been awarded “Innovation in Knee and Back Pain Treatment Company of the Year – NY” by the prestigious NY100 Awards for 2025

Apos: The Innovative Solution for Improved Walking and Reduced Pain

Managing knee osteoarthritis to live better every day

Beyond Pain Management: AposHealth’s Unique Foot-Worn Device Offers New Hope for Joint Pain Sufferers

Battling Chronic Knee Pain in Women

Apos Device Reduces Chronic Knee Pain

Texas RoundUP: Interview With Dr. Nina Cha, VP of Clinical Services at Aposhealth

Avoid Surgery and Injections: How Apos Provides a Safe, Drug-Free Solution for Joint Pain

AposHealth® Wins 2025 International Elite 100 Award for Innovation in Knee & Back Pain Treatment– Recognized for pioneering non-invasive, drug-free pain relief.

Knee Osteoarthritis and How Retraining Gait Alleviates Pain | By Cliff Bleustein, MD, MBA — Global President, CEO, and Director at AposHealth, & Adjunct Professor of Health Economics at NYU Stern School of Business

New Study Finds Apos® Superior to Traditional Physical Therapy for Chronic Low Back Pain

AposHealth wins the 2025 Global Recognition Award for revolutionizing musculoskeletal care with Apos®, a drug-free, patient-centric solution for chronic pain

AposHealth Wins 2024 Global Excellence Award for Best Knee-Pain Relief Device

The European Alliance of Associations for Rheumatology (EULAR) Recommends Considering Apos® for Knee and Hip Osteoarthritis Management

Apos Recognized by NICE & NHS England’s MedTech Funding Mandate Policy as a Cost-Saving Solution in Knee Osteoarthritis

AposHealth® Appoints Ben Feldman as Chief Marketing Officer to Lead The Next Phase of Growth

Apos® Demonstrates 43% Reduction in Healthcare Utilization and Costs for Patients with Knee and Back Pain

AposHealth® Honored with Prestigious Innovations Award from PBGH, an organization dedicated to enhancing healthcare quality and affordability for employees

Apos® Selected as the First Technology Supported by NHS England’s MedTech Funding Mandate for 2024/25

The Honorable David Shulkin M.D., Ninth Secretary, US Department of Veteran Affairs, Joins AposHealth® Board

Apos®, a Non-Invasive Knee Treatment, Proven to Delay Surgery According to a Real-World Study

AposHealth® Awarded Five-Year Federal Supply Schedule Contract by the Department of Veterans Affairs

Introducing the New Apos®: Designed for Better Style, Comfort, and Precision

AposHealth® Partners with TalarMade to Distribute Flagship Product Throughout the UK

AposHealth® Grabs Attention of European Market with Flagship Solution, Apos®

Geisinger launches innovative, non-invasive treatment option for patients with knee pain

A Revolutionary Approach to Using Gold Standard Patient-Reported Outcome Measures in Clinical Practice

“WALK FAST, LIVE LONGER” AposHealth® CEO Featured on The Live Long and Master Aging Podcast

HealthCare Partners Expands Relationship with AposHealth® to Bring an Innovative, Non-Invasive Treatment for Knee Osteoarthritis to Members Through a New Delivery Model

AposHealth® Awarded Research Grant to Support Rebuilding Efforts in the United Kingdom

Highmark Health Collaborates with AposTherapy to Offer Innovative, Non-Invasive Treatment to Highmark Health Plan Members with Knee Pain

Dr. David B. Nash Joins the AposHealth® Advisory Board

AposHealth® CEO Dr. Cliff Bleustein, MD, MBA Featured on Medical Device Made Easy Podcast

Healthcare Global Discusses AposHealth® as a Treatment for MSK Pain Without Surgery or Drugs

Healthfirst New York Formalizes Coverage of an Innovative Therapy Called AposHealth® Designed for Use in Orthopedic Conditions

New Research Shows AposHealth® Significantly Reduces Osteoarthritis Knee Pain

Research published in The Journal of the American Medical Association (JAMA) Shows Knee Osteoarthritis Patients Treated with AposHealth® Experienced Significant Pain Reduction

Apos Medical Assets LTD partners with Spirit Access to decrease the cost of knee pain treatments in the UK

AposHealth® Expands Partnership With Professional Physical Therapy to Offer Its Drug-Free Solution to Knee and Low Back Pain Patients at Additional Massachusetts Locations

AposHealth® Partners With Three Physical Therapy Providers in Queens to Bring a Non-Surgical, Drug-Free Solution to Knee and Lower Back Pain Sufferers in New York

AposHealth® and Ahava Medical & Rehabilitation Center are partnering to bring Brooklyn residents suffering from knee and lower back pain a non-invasive, drug-free alternative to surgery.

AposHealth® Launches Unique Patient Activation Program

Apos Medical Assets Ltd. Announces $11 Million Series A Extension Funding Round Led by Existing Shareholders